A Science and Technology Blog
The Pune-based Serum Institute of India has already begun manufacturing the Oxford vaccine (ChAdOx1 nCoV-19) for novel coronavirus. The company intends to manufacture two-three million doses by end-August. The Pune-based…
Never before have candidate vaccines been developed from scratch, tested on animals and completed early stages of human clinical trials all under six months. This is an acid test for…
The preliminary results of the Phase-1/2 clinical trial of the Oxford vaccine shows the vaccine is safe, well-tolerated, and immunogenic. The vaccine induced strong antibody by day 28 and remained…
With the pandemic raging across many countries and the demand for a safe, efficacious vaccine being huge, availability of an indigenous vaccine will mean guaranteed availability for Indians, while a…
The results of the Phase-1 clinical trial of the Oxford vaccine (ChAdOx1 nCoV-19) to prevent infection by novel coronavirus are expected by the first week of July. Serum Institute of…
While a single dose induced antigen-specific antibody and T cells responses in pigs, the booster dose enhanced the antibody responses with a significant increase in neutralising antibody levels. There was…
Six rhesus macaque monkeys were resistant to reinfection following exposure to novel coronavirus. Compared with nose, the lungs had very less virus when challenged. In another study, the researchers tested…
Serum Institute of India, Pune, will start manufacturing the vaccine the moment the Phase-3 trial begins. The company is confident of making millions of vaccine doses ready by the time…
